In a multivariate analysis of the non-adenocarcinoma subtype, a significant association between TGase 2 expression and DFS was found, suggesting that TGase 2 expression is a prognostic marker only in the non-adenocarcinoma subtype including squamous cell carcinoma. The gene discussed is TGM2; the disease is adenocarcinoma.